Curcumin offers numerous benefits to human health, however these benefits cannot be fully utilized due to its challenges with absorption in the body
Hydrocurc® is an award-winning curcumin specifically designed to increase bioavailability of curcuminoids in the body. This is done so by the specifically designed curcumin particles in Hydrocurc® to freely disperse in water
A published pharmacokinetic study on humans demonstrated Hydrocurc® to provide the highest amount of curcuminoids seen in industry to date from a single dose.
Hydrocurc® is a trademark of Pharmako Biotechnologies Pty Ltd.
Increased bioavailability in HydroCurc® can be attributed to a new dispersion technology, LipiSperse®. LipiSperse® is a novel system tailored to increase the dispersion of crystalline lipophilic agents in aqueous environments. Cold water dispersible (CWD) powders have an equilibrium established between the LipiSperse® on the powder surface and the LipiSperse® in the solution.
A recent pharmacokinetic study on HydroCurc® in humans aimed to compare the pharmacokinetics of a single dose of a commercially available curcumin product with a curcumin-LipiSperse® delivery system.
Hydrocurc® is the most bioavailabile curcumin seen in industry to date, as it provides a CMax of 807 ng/ml from a single dose. Hydrocurc® also had more than double the AUC after 6-h compared to standard curcumin.
500mg Hydrocurc® significantly:
Co-administration of 500mg Hydrocurc® with 18mg iron significantly:
May be an effective ingredient in enhancing cognitive function and reducing adverse effects associated with iron supplementation.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.